Discovery links defective collagen to microbleeds and memory loss
Millions of elderly people face small bleeds in the brain, known as brain microbleeds, which are strongly associated with dementia, cognitive decline and strokes. However, the exact molecular mechanisms behind these conditions remained unclear, mainly due to the lack of suitable animal models that could isolate this pathology from other complications. Research recently published in the journal Brain significantly contributes to filling this critical gap.
Researchers at Ajou University School of Medicine used the advanced gene editing technique CRISPR/Cas9 to selectively deactivate the Col4a1 gene. This gene is responsible for coding a vital structural protein in the walls of cerebral blood vessels. The change was induced in adult mice through a single intravenous injection of a genetically modified virus, AAV-BR1, which delivered the gene-editing machinery directly to the brain’s microvascular endothelial cells.
On the same topic: Study with almost 8 thousand participants confirms effects of collagen on skin elasticity and joint pain
In just three months, the mice developed dozens of microbleeds spread across the cortex and hippocampus, important brain regions. The location and size of these bleeds remarkably replicated what is seen in MRI scans of elderly patients. The burden of these microbleeds increased progressively over six months and could be precisely adjusted by modifying the initial viral dose applied.
Study model with CRISPR/Cas9 reveals details
Unlike existing models, which often mix microbleeds with amyloid plaques or ischemic lesions, this new research platform generates a purely brain microbleed phenotype. This allows scientists to study its effects in isolation, offering a clearer understanding of the condition.
Electron microscopy analysis confirmed that the affected blood vessels had dramatically thinner basement membranes. As these microbleeds accumulated over time, the mice exhibited progressive memory impairment and motor deficits, closely mirroring clinical observations in human patients.
The research team also identified a distinct neuroinflammatory pattern that drives this decline. They noted that reactive astrocytes spread widely and diffusely beyond the sites of individual lesions, while microglial activation remained strictly localized to the damaged areas.
See Also
Court condemns MC Ryan SP for copyright infringement on 34 songs and imposes fine
Motorola razr fold impresses by being lighter than iPhone 17 Pro Max
Singer Robbie Williams reveals autism diagnosis and finds relief in new perspective
More on this story: Collagen peptides extend support for skin, hair, nails and joint health in daily routines
This widespread astrocytic response suggests a novel mechanism where multiple small, scattered lesions act collectively to disorganize broader neural networks and impair overall brain function.
Neuroinflammatory mechanism and confirmation in human data
To bridge these experimental findings with human pathology, researchers analyzed MRI images and genomic data from 836 participants in the BICWALZS biobank, which stores tissues from patients with chronic cerebrovascular diseases.
They found that genetic variants in the TIMP2 gene, which regulates an enzyme responsible for the breakdown of collagen IV, were significantly associated with susceptibility to microbleeds. These variants increased individual risk by 1.50 to 1.96 times. These human genomic data align perfectly with the mouse model, indicating that dysregulation of collagen IV homeostasis is a species-conserved mechanism underlying sporadic cerebral microbleeds.
Full coverage: Latest News (EN)
“This is the first model to generate a pure brain microbleed phenotype through a targeted molecular intervention in the adult brain,” said Byung Gon Kim, MD, professor of neuroscience and neurology at Ajou University and co-corresponding author of the study. He added that “the ability to precisely modulate microbleed burden provides an unprecedented platform for testing future therapies aimed at halting the progression of microbleeds and preserving cognitive function in aging populations.”
